COVID-19 Updates: COVID-19 Resources » Vaccine Update » Updated Visitor Policy » What We're Doing to Keep You Safe »
Trial ID or NCT#
NCT01831882
Status
Purpose
The primary objective of this study is to investigate the biological components of major depression. The investigators are particularity interested in genetic variation and how it contributes to cortisol (because cortisol is higher in severe depression than mild depression or healthy controls) and how it contributes to clinical symptoms, especially suicidal ideation/behavior and psychosis.
Official Title
Identifying Biological Markers for Severe Depression
Eligibility Criteria
Ages Eligible for Study: 18 Years to 70 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes
Investigator(s)
Alan F. Schatzberg
Psychiatrist
Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences
Jennifer Keller
Psychologist
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Contact us to find out if this trial is right for you.
CONTACT
Maureen H Chang, B.S.
(650) 725-4620
View on ClinicalTrials.gov